BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 17113940)

  • 21. The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease.
    Giannicola G; Marceglia S; Rossi L; Mrakic-Sposta S; Rampini P; Tamma F; Cogiamanian F; Barbieri S; Priori A
    Exp Neurol; 2010 Nov; 226(1):120-7. PubMed ID: 20713047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subthalamic stimulation modulates cortical control of urinary bladder in Parkinson's disease.
    Herzog J; Weiss PH; Assmus A; Wefer B; Seif C; Braun PM; Herzog H; Volkmann J; Deuschl G; Fink GR
    Brain; 2006 Dec; 129(Pt 12):3366-75. PubMed ID: 17077105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep brain stimulation of the posterior subthalamic area in the treatment of tremor.
    Blomstedt P; Fytagoridis A; Tisch S
    Acta Neurochir (Wien); 2009 Jan; 151(1):31-6. PubMed ID: 19093072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subthalamic local field potentials after seven-year deep brain stimulation in Parkinson's disease.
    Giannicola G; Rosa M; Servello D; Menghetti C; Carrabba G; Pacchetti C; Zangaglia R; Cogiamanian F; Scelzo E; Marceglia S; Rossi L; Priori A
    Exp Neurol; 2012 Oct; 237(2):312-7. PubMed ID: 22735488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conflict-dependent dynamic of subthalamic nucleus oscillations during moral decisions.
    Fumagalli M; Giannicola G; Rosa M; Marceglia S; Lucchiari C; Mrakic-Sposta S; Servello D; Pacchetti C; Porta M; Sassi M; Zangaglia R; Franzini A; Albanese A; Romito L; Piacentini S; Zago S; Pravettoni G; Barbieri S; Priori A
    Soc Neurosci; 2011; 6(3):243-56. PubMed ID: 21061226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease.
    Priori A; Foffani G; Pesenti A; Tamma F; Bianchi AM; Pellegrini M; Locatelli M; Moxon KA; Villani RM
    Exp Neurol; 2004 Oct; 189(2):369-79. PubMed ID: 15380487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantation of electrodes for deep brain stimulation of the subthalamic nucleus in advanced Parkinson's disease with the aid of intraoperative microrecording under general anesthesia.
    Hertel F; Züchner M; Weimar I; Gemmar P; Noll B; Bettag M; Decker C
    Neurosurgery; 2006 Nov; 59(5):E1138; discussion E1138. PubMed ID: 17143204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraoperative local field recording for deep brain stimulation in Parkinson's disease and essential tremor.
    Holdefer RN; Cohen BA; Greene KA
    Mov Disord; 2010 Oct; 25(13):2067-75. PubMed ID: 20721922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.
    Hohlefeld FU; Huchzermeyer C; Huebl J; Schneider GH; Nolte G; Brücke C; Schönecker T; Kühn AA; Curio G; Nikulin VV
    Neuroscience; 2013 Oct; 250():320-32. PubMed ID: 23876322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
    Timmermann L; Braun M; Groiss S; Wojtecki L; Ostrowski S; Krause H; Pollok B; Südmeyer M; Ploner M; Gross J; Maarouf M; Voges J; Sturm V; Schnitzler A
    Mov Disord; 2008 Jan; 23(2):218-27. PubMed ID: 18044706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement in Parkinson disease by subthalamic nucleus stimulation based on electrode placement: effects of reimplantation.
    Anheim M; Batir A; Fraix V; Silem M; Chabardès S; Seigneuret E; Krack P; Benabid AL; Pollak P
    Arch Neurol; 2008 May; 65(5):612-6. PubMed ID: 18474736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender-related differences in the human subthalamic area: a local field potential study.
    Marceglia S; Mrakic-Sposta S; Foffani G; Cogiamanian F; Caputo E; Egidi M; Barbieri S; Priori A
    Eur J Neurosci; 2006 Dec; 24(11):3213-22. PubMed ID: 17156382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
    Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
    Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling parkinsonian circuitry and the DBS electrode. I. Biophysical background and software.
    Arle JE; Mei LZ; Shils JL
    Stereotact Funct Neurosurg; 2008; 86(1):1-15. PubMed ID: 17881884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational analysis of subthalamic nucleus and lenticular fasciculus activation during therapeutic deep brain stimulation.
    Miocinovic S; Parent M; Butson CR; Hahn PJ; Russo GS; Vitek JL; McIntyre CC
    J Neurophysiol; 2006 Sep; 96(3):1569-80. PubMed ID: 16738214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An electronic device for artefact suppression in human local field potential recordings during deep brain stimulation.
    Rossi L; Foffani G; Marceglia S; Bracchi F; Barbieri S; Priori A
    J Neural Eng; 2007 Jun; 4(2):96-106. PubMed ID: 17409484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Typical variations of subthalamic electrode location do not predict limb motor function improvement in Parkinson's disease.
    McClelland S; Ford B; Senatus PB; Frucht SJ; Winfield LM; Yu Q; Du YE; Pullman SL; McKhann GM; Goodman RR
    J Clin Neurosci; 2009 Jun; 16(6):771-8; discussion 779. PubMed ID: 19324551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic stimulation of the subthalamic nucleus increases daily on-time without dyskinesia in advanced Parkinson's disease.
    Portman AT; van Laar T; Staal MJ; Rutgers AW; Journee HL; Leenders KL
    Parkinsonism Relat Disord; 2006 Apr; 12(3):143-8. PubMed ID: 16460986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease.
    Galati S; Mazzone P; Fedele E; Pisani A; Peppe A; Pierantozzi M; Brusa L; Tropepi D; Moschella V; Raiteri M; Stanzione P; Bernardi G; Stefani A
    Eur J Neurosci; 2006 Jun; 23(11):2923-8. PubMed ID: 16819981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.